Clinical challenges: myeloma and concomitant type 2 diabetes.

Multiple myelomais a malignant plasma celldisorder that accounts for approximately 10% of all hematologic cancers. It is characterized by accumulation of clonal plasma cells, predominantly in the bone marrow. The prevalence of type 2 diabetes is increasing; therefore, it is expected that there will be an increase in the diagnosis of multiple myelomawith concomitant diabetes mellitus. The treatment of multiple myelomaand diabetes mellitusis multifaceted. The coexistence of the two conditions in a patient forms a major challenge for physicians